Medigene AG (WBO:MDG1) Days Payable : 155.67 (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Medigene AG Days Payable?

Medigene AG's average Accounts Payable for the six months ended in Dec. 2023 was €0.62 Mil. Medigene AG's Cost of Goods Sold for the six months ended in Dec. 2023 was €0.72 Mil. Hence, Medigene AG's Days Payable for the six months ended in Dec. 2023 was 155.67.

The historical rank and industry rank for Medigene AG's Days Payable or its related term are showing as below:

WBO:MDG1' s Days Payable Range Over the Past 10 Years
Min: 104.18 Med: 267.71 Max: 1301.33
Current: 138.03

During the past 13 years, Medigene AG's highest Days Payable was 1301.33. The lowest was 104.18. And the median was 267.71.

WBO:MDG1's Days Payable is ranked worse than
51.6% of 717 companies
in the Biotechnology industry
Industry Median: 147.29 vs WBO:MDG1: 138.03

Medigene AG's Days Payable increased from Dec. 2022 (103.28) to Dec. 2023 (155.67). It may suggest that Medigene AG delayed paying its suppliers.

Medigene AG Days Payable Historical Data

The historical data trend for Medigene AG's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medigene AG Days Payable Chart

Medigene AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

1,301.33

255.10

124.93

104.18

108.19

Medigene AG Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Payable	Get a 7-Day Free Trial															159.38	132.79	103.28	150.83	155.67

Competitive Comparison of Medigene AG's Days Payable

For the Biotechnology subindustry, Medigene AG's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medigene AG's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medigene AG's Days Payable distribution charts can be found below:

* The bar in red indicates where Medigene AG's Days Payable falls into.

Medigene AG Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Medigene AG's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (0.634	+	0.34)	/	2 )	/	1.643	*	365
=	0.487					/	1.643	*	365
=	108.19

Medigene AG's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (0.89	+	0.34)	/	2 )	/	0.721	*	365 / 2
=	0.615					/	0.721	*	365 / 2
=	155.67

Medigene AG Days Payable Related Terms

Thank you for viewing the detailed overview of Medigene AG's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Medigene AG (WBO:MDG1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medigene AG (WBO:MDG1) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

MDGEF:USA MDG1:Germany

Address

Lochhamer Strasse 11, Martinsried, Planegg, BY, DEU, 82152

Website

https://www.medigene.com

Medigene AG is an immuno-oncology biotechnology company. focused on developing differentiated T Cell Receptor engineered T cell (TCR-T) therapies for the treatment of multiple solid tumor indications with a high unmet medical need. The operating segments of the organization are Immunotherapies and Other products. Immunotherapies consist of T-cell receptor-based adoptive T-cell therapy and DC vaccines. The group operates in the United States, Germany, and Asia, of which the majority of the revenue is derived from operations in Germany.

Medigene AG (WBO:MDG1) Headlines

No Headlines